TY - JOUR
T1 - Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis
T2 - a custom strategy for preventing proximal humerus fractures
AU - Ochi, Kensuke
AU - Furuya, Takefumi
AU - Ishibashi, Mina
AU - Watanabe, Makiko
AU - Ikari, Katsunori
AU - Taniguchi, Atsuo
AU - Yamanaka, Hisashi
AU - Momohara, Shigeki
N1 - Funding Information:
We thank Dr. Eisuke Inoue and all members of the Institute of Rheumatology, Tokyo Women’s Medical University, for the successful management of the IORRA cohort. We also thank Prof. Y. Toyama and other members of the Department of Orthopedic Surgery, Keio University School of Medicine, for their support. This work was supported in part by the Japan Orthopaedics and Traumatology Foundation, Inc. No. 277 to KO, and by grants-in-aid for scientific research from the Japan Society for the Promotion of Science to KO.
Publisher Copyright:
© 2015, Springer-Verlag Berlin Heidelberg.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - To our knowledge, no prior report focused on the risk factors for proximal humerus fractures in patients with rheumatoid arthritis. The purpose of this study was to evaluate the association between potential risk factors and the occurrence of proximal humerus fractures in patients with rheumatoid arthritis. A total of 11,907 patients with rheumatoid arthritis were enrolled in our observational cohort rheumatoid arthritis study between 2000 and 2012. Self-reported proximal humerus fractures were verified using the patients’ medical records. Cox proportional hazard models were used to analyze the independent contribution of risk factors to the occurrence of proximal humerus fractures. During follow-up (mean 5.6 years), 92 proximal humerus fractures were verified in 91 patients. Multivariate Cox regression analyses estimated that the hazard ratios of sustaining a proximal humerus fracture were 1.37 for every 10-year increase in age [95 % confidence interval (CI) 1.10–1.70; P < 0.01], 1.95 for increases in serum C-reactive protein levels (mg/100 mL; 95 % CI 1.15–3.34; P < 0.05), 2.13 for a history of fractures (95 % CI 1.34–3.40; P < 0.01), 1.07 for the daily prednisolone dose (per mg; 95 % CI 1.01–1.13; P < 0.05), and 1.97 for oral bisphosphonate use (95 % CI 1.20–3.23; P < 0.01). Better control of rheumatoid arthritis with a smaller daily prednisolone dose in elderly patients with a history of fractures may be important for preventing proximal humerus fractures.
AB - To our knowledge, no prior report focused on the risk factors for proximal humerus fractures in patients with rheumatoid arthritis. The purpose of this study was to evaluate the association between potential risk factors and the occurrence of proximal humerus fractures in patients with rheumatoid arthritis. A total of 11,907 patients with rheumatoid arthritis were enrolled in our observational cohort rheumatoid arthritis study between 2000 and 2012. Self-reported proximal humerus fractures were verified using the patients’ medical records. Cox proportional hazard models were used to analyze the independent contribution of risk factors to the occurrence of proximal humerus fractures. During follow-up (mean 5.6 years), 92 proximal humerus fractures were verified in 91 patients. Multivariate Cox regression analyses estimated that the hazard ratios of sustaining a proximal humerus fracture were 1.37 for every 10-year increase in age [95 % confidence interval (CI) 1.10–1.70; P < 0.01], 1.95 for increases in serum C-reactive protein levels (mg/100 mL; 95 % CI 1.15–3.34; P < 0.05), 2.13 for a history of fractures (95 % CI 1.34–3.40; P < 0.01), 1.07 for the daily prednisolone dose (per mg; 95 % CI 1.01–1.13; P < 0.05), and 1.97 for oral bisphosphonate use (95 % CI 1.20–3.23; P < 0.01). Better control of rheumatoid arthritis with a smaller daily prednisolone dose in elderly patients with a history of fractures may be important for preventing proximal humerus fractures.
KW - Fracture
KW - Glucocorticoid
KW - Proximal humerus fracture
KW - Rheumatoid arthritis
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=84955414510&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955414510&partnerID=8YFLogxK
U2 - 10.1007/s00296-015-3371-5
DO - 10.1007/s00296-015-3371-5
M3 - Article
AN - SCOPUS:84955414510
SN - 0172-8172
VL - 36
SP - 213
EP - 219
JO - Rheumatology International
JF - Rheumatology International
IS - 2
ER -